{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T07:40:56Z","timestamp":1768549256603,"version":"3.49.0"},"reference-count":66,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.jaad.2019.03.043","type":"journal-article","created":{"date-parts":[[2019,3,21]],"date-time":"2019-03-21T14:02:44Z","timestamp":1553176964000},"page":"163-172","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Sexual dysfunction in men taking systemic dermatologic medication: A systematic review"],"prefix":"10.1016","volume":"81","author":[{"given":"George A.","family":"Zakhem","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia E.","family":"Goldberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine C.","family":"Motosko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brandon E.","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roger S.","family":"Ho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.jaad.2019.03.043_bib1","doi-asserted-by":"crossref","first-page":"161","DOI":"10.7326\/0003-4819-139-3-200308050-00005","article-title":"Sexual function in men older than 50 years of age: results from the Health Professionals Follow-up Study","volume":"139","author":"Bacon","year":"2003","journal-title":"Ann Intern Med"},{"issue":"13","key":"10.1016\/j.jaad.2019.03.043_bib2","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1001\/jama.1983.03330370046029","article-title":"Impotence in medical clinic outpatients","volume":"249","author":"Slag","year":"1983","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.jaad.2019.03.043_bib3","doi-asserted-by":"crossref","first-page":"414","DOI":"10.2165\/00002018-199308060-00003","article-title":"Drug-induced male sexual dysfunction. An update","volume":"8","author":"Brock","year":"1993","journal-title":"Drug Saf"},{"issue":"2","key":"10.1016\/j.jaad.2019.03.043_bib4","doi-asserted-by":"crossref","first-page":"109","DOI":"10.3233\/JRS-140617","article-title":"One hundred and twenty cases of enduring sexual dysfunction following treatment","volume":"26","author":"Hogan","year":"2014","journal-title":"Int J Risk Saf Med"},{"issue":"6","key":"10.1016\/j.jaad.2019.03.043_bib5","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1111\/j.1743-6109.2007.00563.x","article-title":"Finasteride 5 mg and sexual side effects: how many of these are related to a nocebo phenomenon?","volume":"4","author":"Mondaini","year":"2007","journal-title":"J Sex Med"},{"issue":"3","key":"10.1016\/j.jaad.2019.03.043_bib6","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1515\/hmbci-2015-0015","article-title":"Finasteride, not tamsulosin, increases severity of erectile dysfunction and decreases testosterone levels in men with benign prostatic hyperplasia","volume":"23","author":"Traish","year":"2015","journal-title":"Horm Mol Biol Clin Investig"},{"issue":"3","key":"10.1016\/j.jaad.2019.03.043_bib7","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/S0090-4295(02)02401-9","article-title":"Incidence and severity of sexual adverse experiences in finasteride and placebo-treated men with benign prostatic hyperplasia","volume":"61","author":"Wessells","year":"2003","journal-title":"Urology"},{"key":"10.1016\/j.jaad.2019.03.043_bib8","doi-asserted-by":"crossref","first-page":"e3020","DOI":"10.7717\/peerj.3020","article-title":"Persistent erectile dysfunction in men exposed to the 5\u03b1-reductase inhibitors, finasteride, or dutasteride","volume":"5","author":"Kiguradze","year":"2017","journal-title":"PeerJ"},{"issue":"9","key":"10.1016\/j.jaad.2019.03.043_bib9","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1016\/j.jsxm.2016.07.006","article-title":"Effect of 5alpha-reductase inhibitors on sexual function: a meta-analysis and systematic review of randomized controlled trials","volume":"13","author":"Liu","year":"2016","journal-title":"J Sex Med"},{"issue":"12","key":"10.1016\/j.jaad.2019.03.043_bib10","doi-asserted-by":"crossref","first-page":"4669","DOI":"10.1210\/jc.2016-2726","article-title":"Characteristics of men who report persistent sexual symptoms after finasteride use for hair loss","volume":"101","author":"Basaria","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.jaad.2019.03.043_bib11","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1111\/j.1743-6109.2011.02255.x","article-title":"Persistent sexual side effects of finasteride for male pattern hair loss","volume":"8","author":"Irwig","year":"2011","journal-title":"J Sex Med"},{"issue":"4 Pt 1","key":"10.1016\/j.jaad.2019.03.043_bib12","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/S0190-9622(98)70007-6","article-title":"Finasteride in the treatment of men with androgenetic alopecia. Finasteride Male Pattern Hair Loss Study Group","volume":"39","author":"Kaufman","year":"1998","journal-title":"J Am Acad Dermatol"},{"issue":"10","key":"10.1016\/j.jaad.2019.03.043_bib13","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1001\/archdermatol.2010.256","article-title":"Efficacy and safety of finasteride therapy for androgenetic alopecia: a systematic review","volume":"146","author":"Mella","year":"2010","journal-title":"Arch Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2019.03.043_bib14","first-page":"179","article-title":"Oral finasteride presents with sexual-unrelated withdrawal in long-term treated androgenic alopecia in men","volume":"13","author":"Perez-Mora","year":"2015","journal-title":"Skinmed"},{"issue":"1","key":"10.1016\/j.jaad.2019.03.043_bib15","doi-asserted-by":"crossref","first-page":"47","DOI":"10.4103\/0378-6323.188652","article-title":"Superiority of dutasteride over finasteride in hair regrowth and reversal of miniaturization in men with androgenetic alopecia: a randomized controlled open-label, evaluator-blinded study","volume":"83","author":"Shanshanwal","year":"2017","journal-title":"Indian J Dermatol Venereol Leprol"},{"issue":"9","key":"10.1016\/j.jaad.2019.03.043_bib16","first-page":"1251","article-title":"Efficacy and safety of finasteride therapy for benign prostatic hyperplasia: results of a 2-year randomized controlled trial (the PROSPECT study). PROscar Safety Plus Efficacy Canadian Two year Study","volume":"155","author":"Nickel","year":"1996","journal-title":"CMAJ"},{"issue":"7","key":"10.1016\/j.jaad.2019.03.043_bib17","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1002\/phar.1612","article-title":"Persistent sexual dysfunction and suicidal ideation in young men treated with low-dose finasteride: a pharmacovigilance study","volume":"35","author":"Ali","year":"2015","journal-title":"Pharmacotherapy"},{"issue":"10","key":"10.1016\/j.jaad.2019.03.043_bib18","first-page":"915","article-title":"Inhibitors of 5alpha-reductase-related side effects in patients seeking medical care for sexual dysfunction","volume":"35","author":"Corona","year":"2012","journal-title":"J Endrocinol Invest"},{"issue":"2","key":"10.1016\/j.jaad.2019.03.043_bib19","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1159\/000079595","article-title":"An open, randomized, comparative study of oral finasteride and 5% topical minoxidil in male androgenetic alopecia","volume":"209","author":"Arca","year":"2004","journal-title":"Dermatology"},{"issue":"6","key":"10.1016\/j.jaad.2019.03.043_bib20","doi-asserted-by":"crossref","first-page":"e100237","DOI":"10.1371\/journal.pone.0100237","article-title":"Immunohistochemical evaluation of androgen receptor and nerve structure density in human prepuce from patients with persistent sexual side effects after finasteride use for androgenetic alopecia","volume":"9","author":"Di Loreto","year":"2014","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.jaad.2019.03.043_bib21","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1001\/jamadermatol.2014.1830","article-title":"Androgen levels and semen parameters among former users of finasteride with persistent sexual adverse effects","volume":"150","author":"Irwig","year":"2014","journal-title":"JAMA Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2019.03.043_bib22","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1177\/1557988314538445","article-title":"Persistent sexual, emotional, and cognitive impairment post-finasteride: a survey of men reporting symptoms","volume":"9","author":"Ganzer","year":"2015","journal-title":"Am J Mens Health"},{"issue":"11","key":"10.1016\/j.jaad.2019.03.043_bib23","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1002\/phar.1837","article-title":"Persistent sexual dysfunction with finasteride 1 mg taken for hair loss","volume":"36","author":"Guo","year":"2016","journal-title":"Pharmacotherapy"},{"issue":"11","key":"10.1016\/j.jaad.2019.03.043_bib24","doi-asserted-by":"crossref","first-page":"2927","DOI":"10.1111\/j.1743-6109.2012.02846.x","article-title":"Persistent sexual side effects of finasteride: could they be permanent?","volume":"9","author":"Irwig","year":"2012","journal-title":"J Sex Med"},{"key":"10.1016\/j.jaad.2019.03.043_bib25","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.jsbmb.2017.04.003","article-title":"Neuroactive steroid levels and psychiatric and andrological features in post-finasteride patients","volume":"171","author":"Melcangi","year":"2017","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"13","key":"10.1016\/j.jaad.2019.03.043_bib26","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1093\/jnci\/djm023","article-title":"Longitudinal analysis of sexual function reported by men in the Prostate Cancer Prevention Trial","volume":"99","author":"Moinpour","year":"2007","journal-title":"J Natl Cancer Inst"},{"issue":"4","key":"10.1016\/j.jaad.2019.03.043_bib27","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1093\/jac\/26.4.561","article-title":"Adverse events associated with itraconazole in 189 patients on chronic therapy","volume":"26","author":"Tucker","year":"1990","journal-title":"J Antimicrob Chemother"},{"issue":"Suppl 1","key":"10.1016\/j.jaad.2019.03.043_bib28","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1093\/clinids\/9.Supplement_1.S47","article-title":"Oral treatment of paracoccidioidomycosis and histoplasmosis with itraconazole in humans","volume":"9","author":"Negroni","year":"1987","journal-title":"Rev Infect Dis"},{"issue":"2","key":"10.1016\/j.jaad.2019.03.043_bib29","first-page":"43","article-title":"Glucocorticoids: their role on gonadal function and LH secretion","volume":"21","author":"Contreras","year":"1996","journal-title":"Minerva Endocrinol"},{"issue":"1","key":"10.1016\/j.jaad.2019.03.043_bib30","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1055\/s-2003-37499","article-title":"Unilateral adrenal tumor, erectile dysfunction and infertility in a patient with 21-hydroxylase deficiency: effects of glucocorticoid treatment and surgery","volume":"111","author":"Scaroni","year":"2003","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"9","key":"10.1016\/j.jaad.2019.03.043_bib31","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1097\/00029330-200805010-00009","article-title":"Prevalence and influential factors of erectile dysfunction in male renal transplant recipients: a multiple center survey","volume":"121","author":"Tian","year":"2008","journal-title":"Chin Med J (Engl)"},{"issue":"10","key":"10.1016\/j.jaad.2019.03.043_bib32","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1002\/anr.1780321029","article-title":"Impotence in three rheumatoid arthritis patients treated with methotrexate","volume":"32","author":"Blackburn","year":"1989","journal-title":"Arthritis Rheum"},{"issue":"7","key":"10.1016\/j.jaad.2019.03.043_bib33","first-page":"1821","article-title":"Impotence in a patient with rheumatoid arthritis treated with methotrexate","volume":"27","author":"Thomas","year":"2000","journal-title":"J Rheumatol"},{"issue":"7","key":"10.1016\/j.jaad.2019.03.043_bib34","doi-asserted-by":"crossref","first-page":"e234","DOI":"10.1111\/j.1365-2230.2008.03082.x","article-title":"Reduced libido and erectile dysfunction: rarely reported side-effects of methotrexate","volume":"34","author":"Wylie","year":"2009","journal-title":"Clin Exp Dermatol"},{"issue":"5","key":"10.1016\/j.jaad.2019.03.043_bib35","first-page":"354","article-title":"Impotence caused by methotrexate treatment [in Danish]","volume":"170","author":"Penninga","year":"2008","journal-title":"Ugeskrift Laeger"},{"issue":"7","key":"10.1016\/j.jaad.2019.03.043_bib36","doi-asserted-by":"crossref","first-page":"e467","DOI":"10.1111\/j.1365-2230.2009.03528.x","article-title":"Peyronie's disease associated with methotrexate therapy","volume":"34","author":"May","year":"2009","journal-title":"Clin Exp Dermatol"},{"issue":"6","key":"10.1016\/j.jaad.2019.03.043_bib37","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1093\/rheumatology\/31.6.425","article-title":"Methotrexate associated Peyronie's disease in the treatment of rheumatoid arthritis","volume":"31","author":"Phelan","year":"1992","journal-title":"Br J Rheumatol"},{"issue":"6","key":"10.1016\/j.jaad.2019.03.043_bib38","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1046\/j.1365-2133.2002.473211.x","article-title":"Thalidomide and sexual dysfunction in men","volume":"146","author":"Pouaha","year":"2002","journal-title":"Br J Dermatol"},{"issue":"10","key":"10.1016\/j.jaad.2019.03.043_bib39","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.3324\/haematol.11095","article-title":"Thalidomide induced impotence in male hematology patients: a common but ignored complication?","volume":"92","author":"Murphy","year":"2007","journal-title":"Haematologica"},{"issue":"6","key":"10.1016\/j.jaad.2019.03.043_bib40","doi-asserted-by":"crossref","first-page":"443","DOI":"10.7326\/0003-4819-128-6-199803150-00004","article-title":"Thalidomide in the treatment of the mucocutaneous lesions of the Beh\u00e7et syndrome: a randomized, double-blind, placebo-controlled trial","volume":"128","author":"Hamuryudan","year":"1998","journal-title":"Ann Intern Med"},{"issue":"7","key":"10.1016\/j.jaad.2019.03.043_bib41","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1001\/archderm.1990.01670310085012","article-title":"Crossover study of thalidomide vs placebo in severe recurrent aphthous stomatitis","volume":"126","author":"Revuz","year":"1990","journal-title":"Arch Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2019.03.043_bib42","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.yebeh.2011.04.058","article-title":"Gabapentin-induced sexual dysfunction","volume":"21","author":"Kaufman","year":"2011","journal-title":"Epilepsy Behav"},{"issue":"3","key":"10.1016\/j.jaad.2019.03.043_bib43","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1097\/00007611-200093030-00020","article-title":"Improved sexual function in three men taking lamotrigine for epilepsy","volume":"93","author":"Husain","year":"2000","journal-title":"South Med J"},{"issue":"1","key":"10.1016\/j.jaad.2019.03.043_bib44","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1034\/j.1399-5618.2001.030109.x","article-title":"Gabapentin-induced anorgasmia as a cause of noncompliance in a bipolar patient","volume":"3","author":"Montes","year":"2001","journal-title":"Bipolar Disord"},{"issue":"1","key":"10.1016\/j.jaad.2019.03.043_bib45","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1097\/NRL.0b013e3181454823","article-title":"Gabapentin and sexual dysfunction: report of two cases","volume":"14","author":"Dalal","year":"2008","journal-title":"Neurologist"},{"issue":"9","key":"10.1016\/j.jaad.2019.03.043_bib46","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1212\/WNL.53.9.2209","article-title":"Gabapentin-induced anorgasmia","volume":"53","author":"Clark","year":"1999","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.jaad.2019.03.043_bib47","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.amjopharm.2011.04.007","article-title":"Anorgasmia with gabapentin may be common in older patients","volume":"9","author":"Perloff","year":"2011","journal-title":"Am J Geriatr Pharmacother"},{"issue":"2","key":"10.1016\/j.jaad.2019.03.043_bib48","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.yebeh.2005.12.001","article-title":"Erectile dysfunction associated with pregabalin add-on treatment in patients with partial seizures: five case reports","volume":"8","author":"Hitiris","year":"2006","journal-title":"Epilepsy Behav"},{"issue":"3","key":"10.1016\/j.jaad.2019.03.043_bib49","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1684\/epd.2013.0592","article-title":"Anorgasmia during pregabalin add-on therapy for partial seizures","volume":"15","author":"Calabro","year":"2013","journal-title":"Epileptic Disord"},{"issue":"7","key":"10.1016\/j.jaad.2019.03.043_bib50","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1111\/jsm.12458","article-title":"Association between neuropathic pain, pregabalin treatment, and erectile dysfunction","volume":"11","author":"Bozkurt","year":"2014","journal-title":"J Sex Med"},{"issue":"3","key":"10.1016\/j.jaad.2019.03.043_bib51","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.yebeh.2010.07.026","article-title":"Pregabalin-induced severe delayed ejaculation","volume":"19","author":"Calabro","year":"2010","journal-title":"Epilepsy Behav"},{"issue":"10","key":"10.1016\/j.jaad.2019.03.043_bib52","first-page":"974","article-title":"Erectile dysfunction during isotretinoin therapy [in Spanish]","volume":"29","author":"Tirado Sanchez","year":"2005","journal-title":"Actas Urol Esp"},{"issue":"8916","key":"10.1016\/j.jaad.2019.03.043_bib53","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/S0140-6736(94)92803-7","article-title":"Effects of isotretinoin on male reproductive system","volume":"344","author":"Coleman","year":"1994","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.jaad.2019.03.043_bib54","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1001\/archderm.1991.01680030151029","article-title":"Erectile dysfunction in etretinate treatment","volume":"127","author":"Reynolds","year":"1991","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2019.03.043_bib55","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/1757-1626-2-210","article-title":"Acitretin-associated erectile dysfunction: a case report","volume":"2","author":"Rossi","year":"2009","journal-title":"Cases J"},{"issue":"1","key":"10.1016\/j.jaad.2019.03.043_bib56","first-page":"90","article-title":"Sexual dysfunction in a patient treated with etretinate","volume":"68","author":"Halkier-Sorensen","year":"1988","journal-title":"Acta Derm Venereol"},{"issue":"5","key":"10.1016\/j.jaad.2019.03.043_bib57","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1002\/j.1939-4640.1996.tb01828.x","article-title":"Effect of finasteride on human testicular steroidogenesis","volume":"17","author":"Castro-Magana","year":"1996","journal-title":"J Androl"},{"issue":"11","key":"10.1016\/j.jaad.2019.03.043_bib58","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1111\/j.1742-1241.2012.03010.x","volume":"66","author":"Kaplan","year":"2012","journal-title":"Int J Clin Pract"},{"issue":"6","key":"10.1016\/j.jaad.2019.03.043_bib59","first-page":"1934","article-title":"Inhibition of steroid 5 alpha-reductase with finasteride: sleep-related erections, potency, and libido in healthy men","volume":"80","author":"Cunningham","year":"1995","journal-title":"J Clin Endrocinol Metab"},{"issue":"3","key":"10.1016\/j.jaad.2019.03.043_bib60","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/j.1464-410X.2011.10195.x","article-title":"Comparison of dutasteride and finasteride for treating benign prostatic hyperplasia: the Enlarged Prostate International Comparator Study (EPICS)","volume":"108","author":"Nickel","year":"2011","journal-title":"BJU Int"},{"key":"10.1016\/j.jaad.2019.03.043_bib61","doi-asserted-by":"crossref","first-page":"i4823","DOI":"10.1136\/bmj.i4823","article-title":"Risk of erectile dysfunction associated with use of 5-alpha reductase inhibitors for benign prostatic hyperplasia or alopecia: population based studies using the Clinical Practice Research Datalink","volume":"354","author":"Hagberg","year":"2016","journal-title":"BMJ"},{"issue":"4","key":"10.1016\/j.jaad.2019.03.043_bib62","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s13555-015-0084-3","article-title":"Randomized questionnaire based case-control research study on evaluation of sexual function in Indian patients taking oral finasteride for androgenetic alopecia","volume":"5","author":"Narasimhalu","year":"2015","journal-title":"Dermatol Ther"},{"issue":"7","key":"10.1016\/j.jaad.2019.03.043_bib63","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1001\/archderm.140.7.857","article-title":"Evaluation of sexual function with an international index of erectile function in subjects taking finasteride for androgenetic alopecia","volume":"140","author":"Tosti","year":"2004","journal-title":"Arch Dermatol"},{"issue":"5","key":"10.1016\/j.jaad.2019.03.043_bib64","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1046\/j.1468-3083.2001.00315.x","article-title":"Evaluation of sexual function in subjects taking finasteride for the treatment of androgenetic alopecia","volume":"15","author":"Tosti","year":"2001","journal-title":"J Eur Acad Dermatol Venerol"},{"issue":"3","key":"10.1016\/j.jaad.2019.03.043_bib65","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1097\/00004714-200006000-00016","article-title":"Anorgasmia in a patient with bipolar disorder type 1 treated with gabapentin","volume":"20","author":"Brannon","year":"2000","journal-title":"J Clin Psychopharmacol"},{"issue":"3","key":"10.1016\/j.jaad.2019.03.043_bib66","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/ijir.2009.7","article-title":"A population-based survey of sexual activity, sexual problems and associated help-seeking behavior patterns in mature adults in the United States of America","volume":"21","author":"Laumann","year":"2009","journal-title":"Int J Impot Res"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962219304591?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962219304591?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:51:34Z","timestamp":1759272694000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962219304591"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":66,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["S0190962219304591"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2019.03.043","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sexual dysfunction in men taking systemic dermatologic medication: A systematic review","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2019.03.043","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 by the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}